Stocks · Healthcare · Drug Manufacturers - Specialty & Generic
Alpha Teknova, Inc. TKNO
$8.99 +1.47% Close, Oct 2, 2026 · NASDAQ · Market cap $482.0M
Strong trend
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -36.2% from -55.0% a year earlier.
- The stock is in an uptrend: above its 200-day average for 91 trading days, with the 50-day average above the 200-day.
- Revenue over the last four quarters was $43.7M, up 12.3% from a year earlier, accelerating from 9.3% a quarter earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 43%
- Revenue growth, 3-year CAGRBottom 22%
- Revenue growth accelerationTop 23%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 48%
- Gross marginBottom 23%
- Operating marginBottom 38%
- Accruals (lower is better)Top 31%
- Interest coverBottom 29%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 40%
- Free-cash-flow yieldTop 40%
- EBITDA / enterprise valueTop 43%
- Sales / enterprise valueBottom 28%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 47%
- 6-month returnTop 2%
- 1-year return vs S&P 500Top 30%
- Distance from 52-week highTop 6%
- Trend checklist (0–4)Top 7%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 31%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyTop 10%
- Upside to consensus price targetBottom 6%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 50%
- Maximum drawdown, 3 yearsBottom 33%
- Beta vs S&P 500 (lower is better)Bottom 13%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 9.3% | 12.3% | ↑ |
| Gross margin | 23.7% | 33.9% | ↑ |
| Operating margin | -55.0% | -36.2% | ↑ |
| FCF margin | -27.0% | -16.4% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 12.3% | 9.3% | ↑ | Top 43% |
| Gross margin | 33.9% | 23.7% | ↑ | Bottom 23% |
| Operating margin | -36.2% | -55.0% | ↑ | Bottom 38% |
| Net margin | -38.4% | -55.2% | ↑ | — |
| Free-cash-flow margin | -16.4% | -27.0% | ↑ | — |
| Return on invested capital | -17.4% | — | Top 48% | |
| Revenue growth, 3-year CAGR | -0.7% | — | Bottom 22% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -11.2%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 4.8%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -7.1 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -18.1×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.08%
- Shareholder yield
- -0.08%
- Share count change, 1 year
- +0.3%
- Share count change, 3-year CAGR
- +23.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- +14.3%
- Average 2-day reaction, last 8
- +0.8%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $8.00
- Target vs current price
- -11.0%
- Analysts with a rating
- 3
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | +28.8% | +1.6% | +27.5% | +28.3% | — |
| May 6, 2026 | +13.6% | -2.7% | +6.7% | +37.2% | +33.7% |
| Feb 26, 2026 | +0.0% | +0.9% | +3.5% | +34.5% | +71.2% |
| Nov 6, 2025 | +14.7% | -2.8% | -9.9% | -2.4% | -50.7% |
| Aug 7, 2025 | +30.3% | -0.2% | +12.2% | -2.5% | +16.3% |
| May 8, 2025 | +18.2% | +6.3% | +8.8% | -3.7% | -26.9% |
| Mar 4, 2025 | +8.3% | +3.1% | -5.8% | -11.4% | -1.0% |
| Nov 7, 2024 | -36.4% | +0.0% | -9.3% | +14.5% | +41.7% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.06 | -$0.08 | +28.8% | $12.2M |
| May 6, 2026 | -$0.08 | -$0.09 | +13.6% | $11.1M |
| Feb 26, 2026 | -$0.09 | -$0.09 | +0.0% | $10.0M |
| Nov 6, 2025 | -$0.08 | -$0.09 | +14.7% | $10.5M |
| Aug 7, 2025 | -$0.07 | -$0.10 | +30.3% | $10.3M |
| May 8, 2025 | -$0.09 | -$0.11 | +18.2% | $9.8M |
| Mar 4, 2025 | -$0.11 | -$0.12 | +8.3% | $9.3M |
| Nov 7, 2024 | -$0.15 | -$0.11 | -36.4% | $9.6M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 11.52× | — | — | Bottom 28% |
| Free-cash-flow yield | -1.48% | — | — | Top 40% |
| Earnings yield | -3.50% | — | — | Top 40% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 44
- Days above the 200-day average
- 91
- 50-day average slope (20 days)
- +16.7%
- 200-day average slope (20 days)
- +8.1%
- Distance from 50-day average
- +26.2%
- Distance from 200-day average
- +98.1%
- RSI (14)
- 69.8
- Relative volume
- 0.94×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 55.8%
- Volatility vs own 5-year history
- 3th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 2.04
- Correlation with S&P 500
- 0.34
- Current drawdown from 1-year high
- -3.6%
- Maximum drawdown, 3 years
- -79.6%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jun 28, 2021 | Jul 5, 2024 | -95.7% | 759 days | Not yet recovered |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $482.0M
- EPS, diluted (TTM)
- -$0.32
- Revenue (TTM)
- $43.7M
- 52-week range
- $1.91 – $9.48
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $36.9M | $41.4M | $36.7M | $37.7M | $40.5M |
| Gross profit | $17.6M | $17.5M | $10.3M | $7.2M | $13.4M |
| Operating income | -$12.0M | -$49.7M | -$35.6M | -$26.1M | -$17.0M |
| Net income | -$9.8M | -$47.5M | -$36.8M | -$26.7M | -$17.3M |
| EPS (diluted) | -$0.35 | -$1.69 | -$1.16 | -$0.57 | -$0.32 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.6M | $9.3M | $9.8M | $10.3M | $10.5M | $10.0M | $11.1M | $12.2M |
| Net income | -$7.6M | -$5.7M | -$4.6M | -$3.6M | -$4.3M | -$4.8M | -$4.6M | -$3.2M |
| EPS (diluted) | -$0.17 | -$0.11 | -$0.09 | -$0.07 | -$0.08 | -$0.09 | -$0.09 | -$0.06 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$9.1M | -$27.4M | -$18.8M | -$12.4M | -$8.6M |
| Capital expenditure | -$19.9M | -$28.1M | -$7.9M | -$1.1M | -$1.1M |
| Free cash flow | -$28.9M | -$55.5M | -$26.7M | -$13.5M | -$9.8M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $102.7M | $439,000 | $22.5M | $15.1M | $211,000 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $17.4M
- Total assets
- $95.9M
- Total liabilities
- $33.3M
- Total debt
- $27.4M
- Net debt
- $21.4M
- Shareholders’ equity
- $62.6M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 1,578,870
- Days to cover
- 10.83
- Change vs previous report
- +1.7%
FINRA short interest, settlement date Sep 15, 2026.